Working… Menu

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04009577
Recruitment Status : Recruiting
First Posted : July 4, 2019
Last Update Posted : December 3, 2019
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 13, 2020
Estimated Study Completion Date : July 2, 2020